C&B Minicast

Cognitive & Behavioral Health Center of Charleston

Welcome to the Cognitive & Behavioral Health Center of Charleston’s podcast channel!Our Minicasts offer insightful, bite-sized episodes led by our experienced directors. From discussions on trauma and mental health awareness to topics on community well-being, our episodes provide valuable information and practical tips. Tune in for quick, thought-provoking content aimed at fostering better mental health and a stronger community.

  1. SEP 21

    Can Psychedelics Change the Future of Mental Health Treatment?

    Send us a text Can psychedelics change the future of mental health treatment? In this episode, we provide an overview of psychedelic research over the past five years.  Studies on psilocybin, MDMA, ketamine and esketamine are discussed.   Curious about participating in a trial? Visit ClinicalTrials.gov. #CBHealthCharleston #MentalHealthAwareness #PsychedelicResearch #KetamineTherapy #PsilocybinHealing #MDMAWellness #ClinicalTrials American  Psychiatric Association. (2022). Position  statement on the use of psychedelic and empathogenic agents for mental health conditions. American Psychiatric Association. https://www.psychiatry.org/ Bogenschutz, M. P., Ross, S., Bhatt, S., Baron, T., Forcehimes, A. A., Laska, E., ... & Khalsa, S. S. (2022). Percentage of heavy drinking days following psilocybin-assisted treatment for alcohol use disorder: A randomized clinical trial. JAMA  Psychiatry, 79(10), 953–962. https://doi.org/10.1001/jamapsychiatry.2022.2096 Carhart-Harris, R. L., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., ... & Nutt, D. J. (2021). Trial of psilocybin versus escitalopram for depression. New  England Journal of Medicine, 384(15), 1402–1411. https://doi.org/10.1056/NEJMoa2032994 Daly, E. J., Trivedi, M. H., Janik, A., Li, H., Zhang, Y., Li, X., ... & Drevets, W. C. (2019). Efficacy of esketamine nasal spray plus oral antidepressant vs antidepressant plus placebo for relapse prevention in treatment-resistant depression: A randomized clinical trial. JAMA  Psychiatry, 76(9), 893–903. https://doi.org/10.1001/jamapsychiatry.2019.1189 Goodwin, G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., ... & Wiegand, F. (2022). Single-dose psilocybin for a treatment-resistant episode of major depression. New  England Journal of Medicine, 387(18), 1637–1648. https://doi.org/10.1056/NEJMoa2206443

    13 min

About

Welcome to the Cognitive & Behavioral Health Center of Charleston’s podcast channel!Our Minicasts offer insightful, bite-sized episodes led by our experienced directors. From discussions on trauma and mental health awareness to topics on community well-being, our episodes provide valuable information and practical tips. Tune in for quick, thought-provoking content aimed at fostering better mental health and a stronger community.

You Might Also Like